86 related articles for article (PubMed ID: 17395368)
1. FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity.
Jiang F; Ai J; Xiao W; Wang Z
Cancer Lett; 2007 Aug; 253(2):265-72. PubMed ID: 17395368
[TBL] [Abstract][Full Text] [Related]
2. ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.
Xiao W; Jiang F; Wang Z
Prostate; 2006 Jan; 66(1):1-12. PubMed ID: 16114057
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.
Hahn J; Xiao W; Jiang F; Simone F; Thirman MJ; Wang Z
Prostate; 2007 Feb; 67(2):146-53. PubMed ID: 17044034
[TBL] [Abstract][Full Text] [Related]
4. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
Simone F; Luo RT; Polak PE; Kaberlein JJ; Thirman MJ
Blood; 2003 Mar; 101(6):2355-62. PubMed ID: 12446457
[TBL] [Abstract][Full Text] [Related]
5. Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells.
Qiao Z; Wang D; Hahn J; Ai J; Wang Z
Prostate; 2014 Feb; 74(2):113-20. PubMed ID: 24272884
[TBL] [Abstract][Full Text] [Related]
6. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
Xiao W; Zhang Q; Habermacher G; Yang X; Zhang AY; Cai X; Hahn J; Liu J; Pins M; Doglio L; Dhir R; Gingrich J; Wang Z
Oncogene; 2008 Mar; 27(11):1536-44. PubMed ID: 17873910
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2/U19.
Wan X; Ji W; Mei X; Zhou J; Liu JX; Fang C; Xiao W
PLoS One; 2010 Feb; 5(2):e9118. PubMed ID: 20161747
[TBL] [Abstract][Full Text] [Related]
8. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.
Su F; Pascal LE; Xiao W; Wang Z
Oncogene; 2010 Jan; 29(3):421-31. PubMed ID: 19826414
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish eaf1 and eaf2/u19 mediate effective convergence and extension movements through the maintenance of wnt11 and wnt5 expression.
Liu JX; Hu B; Wang Y; Gui JF; Xiao W
J Biol Chem; 2009 Jun; 284(24):16679-16692. PubMed ID: 19380582
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2016 May; 7(20):29245-54. PubMed ID: 27058417
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate.
Su F; Correa BR; Luo J; Vencio RZ; Pascal LE; Wang Z
Cancer Microenviron; 2013 Dec; 6(3):247-61. PubMed ID: 23440596
[TBL] [Abstract][Full Text] [Related]
13. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.
Simone F; Polak PE; Kaberlein JJ; Luo RT; Levitan DA; Thirman MJ
Blood; 2001 Jul; 98(1):201-9. PubMed ID: 11418481
[TBL] [Abstract][Full Text] [Related]
14. ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells.
Liu L; Ai J; Xiao W; Liu J; Wang Y; Xin D; He Z; Guo Y; Wang Z
Prostate; 2010 May; 70(7):797-805. PubMed ID: 20166137
[TBL] [Abstract][Full Text] [Related]
15. U19/Eaf2 binds to and stabilizes von hippel-lindau protein.
Xiao W; Ai J; Habermacher G; Volpert O; Yang X; Zhang AY; Hahn J; Cai X; Wang Z
Cancer Res; 2009 Mar; 69(6):2599-606. PubMed ID: 19258512
[TBL] [Abstract][Full Text] [Related]
16. Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
Pascal LE; Su F; Wang D; Ai J; Song Q; Wang Y; O'Malley KJ; Cross B; Rigatti LH; Green A; Dhir R; Wang Z
Neoplasia; 2019 Aug; 21(8):752-764. PubMed ID: 31229879
[TBL] [Abstract][Full Text] [Related]
17. The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.
Pascual-Le Tallec L; Simone F; Viengchareun S; Meduri G; Thirman MJ; Lombès M
Mol Endocrinol; 2005 May; 19(5):1158-69. PubMed ID: 15650021
[TBL] [Abstract][Full Text] [Related]
18. ELL-associated factors EAF1/2 negatively regulate HIV-1 transcription through inhibition of Super Elongation Complex formation.
Liu R; Chen C; Li Y; Huang Q; Xue Y
Biochim Biophys Acta Gene Regul Mech; 2020 May; 1863(5):194508. PubMed ID: 32087315
[TBL] [Abstract][Full Text] [Related]
19. Eaf1 and Eaf2 negatively regulate canonical Wnt/β-catenin signaling.
Liu JX; Zhang D; Xie X; Ouyang G; Liu X; Sun Y; Xiao W
Development; 2013 Mar; 140(5):1067-78. PubMed ID: 23364330
[TBL] [Abstract][Full Text] [Related]
20. Promoter analysis of TFPT (FB1), a molecular partner of TCF3 (E2A) in childhood acute lymphoblastic leukemia.
Brambillasca F; Mosna G; Ballabio E; Biondi A; Boulukos KE; Privitera E
Biochem Biophys Res Commun; 2001 Nov; 288(5):1250-7. PubMed ID: 11700047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
